Objective: To investigate whether a probiotic supplementation to cART patients modifies the cerebrospinal fluid (CSF) proteome and improves neurocognitive impairment. Methods: 26 CSF samples from 13 HIV-positive patients [six patients living with HIV (PLHIV) and seven patients with a history of AIDS (PHAIDS)] were analyzed. All patients underwent to neurocognitive evaluation and blood sampling at baseline and after 6 months of oral bacteriotherapy. Immune phenotyping and activation markers (CD38 and HLA-DR) were evaluated on peripheral blood mononuclear cells (PBMC). Plasma levels of IL-6, sCD14, and MIP-1β were detected, by enzyme-linked immunosorbent assay (ELISA). Functional proteomic analysis of CSF sample was conducted by two-dimensional electrophoresis; a multivariate analysis was performed by principal component analysis (PCA) and data were enriched by STRING software. Results: Oral bacteriotherapy leads to an improvement on several cognitive test and neurocognitive performance in both groups of HIV-positive subjects. A reduction in the percentage of CD4 + CD38 + HLA-DR + T cells was also observed at peripheral level after the probiotic intake (p = 0.008). In addition, the probiotic supplementation to cART significantly modifies protein species composition and abundance at the CSF level, especially those related to inflammation (β2-microglobulin p = 0.03; haptoglobin p = 0.06; albumin p = 0.003; hemoglobin p = 0.003; immunoglobulin heavy chains constant region p = 0.02, transthyretin p = 0.02) in PLHIV and PHAIDS. Conclusions: Our results suggest that oral bacteriotherapy as a supplement to cART could exert a role in the amelioration of inflammation state at peripheral and CNS level.
Introduction
Notwithstanding the antiretroviral treatment, most HIV-infected individuals show a high prevalence of non-AIDS defining neurologic conditions collected under the name of HIV-associated neurocognitive disorders (HAND) (Heaton et al. 2010 (Heaton et al. , 2011 . Neuroinflammation seems to be aggravated by bacterial products leaking out of the colon into the bloodstream and causing a greater level of inflammation throughout the body (Vera et al. 2015 (Vera et al. , 2016 Spudich et al. 2005 Spudich et al. , 2011 Banks et al. 2015; Gold et al. 2014; Cinque et al. 2007 ). Since imbalances of gut bacterial species (dysbiosis) and increased microbial translocation have been observed in HIV-positive patients (Xu et al. 2013; Salas and Chang 2014; Hunt et al. 2014 ), any intervention which is able to protect the gut barrier should be explored. Previously, we have shown that the supplementation with a high concentration multistrain probiotic formulation to cART patients was associated with the recovery of the gut epithelial barrier integrity, a reduction in both intraepithelial lymphocyte density and enterocyte apoptosis, and an improvement in mitochondrial morphology (d' Ettorre et al. 2014 Ettorre et al. , 2017 Carter et al. 2016; D'Angelo et al. 2017; Pinacchio et al. 2018 ). We also observed that different neurocognitive test scores improved significantly after probiotic supplementation (Ceccarelli et al. 2017a, b; Akbari et al. 2016) .
Nevertheless, our hypothesis was that HIV directly impairs the neurological system, independently from the years of exposure to the virus, the disease's severity and the immunological status of patient. Given these considerations, the scope of our present research was to investigate if, according to a previous diagnosis of AIDS, there were differentially abundant protein species associated with the HIV-related neurocognitive impairment.
Moreover, we wanted to investigate if a modification of the cerebrospinal fluid (CSF) proteome occurs in cART patients after oral bacteriotherapy, in order to confirm the previously observed gut and neurological improvements at the molecular level.
Materials and methods

Study population
In this longitudinal interventional non-randomized study, we included 13 eligible HIV-positive subjects: six patients living with HIV (PLHIV) and seven patients with a history of AIDS (PHAIDS) referring for routine visits to the HIV Outpatient Clinic of the Department of Infectious Diseases of BSapienzaÛ niversity of Rome. The inclusion criteria were (1) HIVpositive patients who had signed the informed consent, (2) women or men at least 18 years of age, (3) in cART with HIV-RNA < 50 copies/ml, and CD4 counts > 400 cells/mm 3 .
Exclusion criteria were (1) known allergy or intolerance to the product, (2) diarrhea, (3) history of or current inflammatory diseases of the small or large intestine, (4) any past or current systemic malignancy, (5) previous or actual drug addiction, (6) use of antibiotics or probiotics during the 3 weeks prior the enrollment, (7) previous or actual psychiatric disorders, (8) previous or actual neurological disorders, (9) positive PCR on CSF for any of the following pathogens: CMV, EBV, HSV1, HSV2, VZV, HHV8, BKV, JCV, pregnancy.
Because lumbar puncture is considered a procedure with several risks and in literature there is no reported study where lumbar puncture was performed in the control arm, our institution considered it unethical to have a control group undergoing such a procedure.
Standard protocol approvals, registration, and patients' consents
The study was approved by the internal committee of the Infectious Diseases Department and by the Ethics Committee of BSapienza^University of Rome. A written informed consent was obtained from all patients prior to enrollment.
Study timeline and investigational compound
All participants underwent cerebrospinal fluid (CSF) sampling and neurocognitive evaluation at baseline (T0) and after 6 months (T6) of supplementation with a commercially available multistrain probiotic formulation ( 
Specimen processing
About 20 mL of whole blood was collected by venipuncture in Vacutainer tubes containing EDTA (BD Biosciences, San Jose, CA, USA) at each study visit. Peripheral blood mononuclear cells were separated by Ficoll gradient centrifugation (Lympholyte; Cedarlane Labs, Hornby, ON, Canada) and washed twice in phosphate-buffered saline solution (Ceccarelli et al. 2017b) . Freshly isolated PBMCs were used immediately for immune phenotyping and activation staining. About 10 mL of whole blood was collected by BD Vacutainer Plus Plastic Serum. After centrifuge, serum was stored in aliquots at − 80°C.
T cell phenotyping by flow cytometry
Phenotypes and activation markers were evaluated by Miltenyi Biotec flow cytometer-MACSQuant Analyzer (eight fluorescence channels, three lasers) on freshly isolated PBMC. Immune activation was evaluated by multiparameter flow cytofluorimetric analysis by the following antihuman monoclonal antibodies: CD3-PerCP, CD4-APC-Vio770, CD38-APC, and HLA-DR-PE (Miltenyi Biotec, Bergisch Gladbach, Germany).
Enzyme-linked immunosorbent assay
Plasma levels of IL-6, sCD14, and MIP-1β were detected by enzyme-linked immunosorbent assay (ELISA) kit (R&D System, MN, USA) based on an indirect assay with an antigen-antiserum bound and a conjugate antibody using a 3,3′,5, 5′-tetramethylbenzidine (TMB) as a substrate for the detection. For cytokine detection, we used an ELISA assay with an anti-IL6, sCD14, and MIP-1β antibody precoated microplate; a cytokines antiserum; a conjugate enzyme (goat antirabbit immunoglobulins conjugated with peroxidase); and a substrate for the reaction (containing tetramethylbenzidine, substrate buffer, and hydrogen peroxide). The reaction was monitored at 450 nm. Quantification was achieved by comparing their absorbance with a reference curve (prepared with known standard concentrations).
Virologic analysis
HIV-1 RNA copy number was measured in plasma by using Versant kPCR (Siemens Healthcare Diagnostic, Inc., Tarrytown, NY). The detection limit was 37 HIV-1 RNA copies/mL.
Neuropsychological investigation
Neuropsychological tests were performed by a trained neuropsychologist in order to explore patients' ability in the following areas: verbal, language, attention, learning memory, working memory, abstraction, executive functions, processing speed of information (sensory-perceptual and motor). The test battery included Rey-Osterrieth Complex Figure Test (ROCF) to evaluate participants' recognition and recall skills for non-verbal contents; Rey Auditory Verbal Learning Test (RAVLT) to evaluate short-term auditory verbal memory, rate of learning, and retention of information; test of weights and measures estimation (STEP) to evaluate abstraction skills; visual search test (attention matrices test) to evaluate attention skills; verbal fluency test (FAB) to evaluate executive functions and the ability to switch between different tasks; test of phonological and semantic verbal fluency (respectively PVF and SVF) to evaluate phonological and semantic supplies and the ability to access them; Raven's Standard Progressive Matrices (SPM) to evaluate abstract reasoning and problem solving capabilities; digit span test to evaluate short-term memory and executive functions; Corsi block-tapping test (CBTT) to evaluate short-term spatial memory and executive functions; Aachener Aphasia Test (AAT) to evaluate the presence of aphasia among study participants; and trail making test A and B (TMT A and TMT B) to evaluate visual-spatial attention and motor skills. To minimize the possible influence of the practical effect on neuropsychological performances, parallel/alternate forms were used.
Moreover, effect sizes were also extracted for descriptive purposes as well as baseline and post-concussion means and standard deviations for the T0 and T6.
Functional proteomic analysis of CSF by two-dimensional electrophoresis
Differential proteomic analysis was conducted on T0 and T6 CSF samples of participants. Sample preparation was performed as reported: 333 μl of CSF was precipitated 1:4 in cold acetone and centrifuged at 10,000×g for 15 min. The supernatant was eliminated and the pellet solubilized in 5 μl of 5% w/v SDS and 2.3% w/v DTE and heated at 95°C for 7 min. Rehydration buffer (8 M UREA, 2 M Thiourea, 1% w/v DTE, 0.4% w/v CHAPS, and traces of bromophenol blue) was, then, added to reach a total volume of 450 μl, containing 60 μg of total proteins. Preparative gels were processed as the previous ones, starting from 3 ml of CSF to obtain a final protein load of 540 μg.
CSF samples were resolved by two-dimensional electrophoresis (2DE), as reported (Hochstrasser et al. 1988 ). Spots were considered differentially abundant between two conditions when the ratio of the percentage of relative volume (%V: Vol of a single spot divided by the total volume of spots computed over the whole image and expressed in percentage) means was greater than twofold. Statistical non-parametric Mann-Whitney test (p ≤ 0.05), by IBM SPSS® software platform, was performed to determine if two sets of data were significantly different from each other. %V of differentially abundant spots was used to perform multivariate analysis by principal component analysis (PCA) simplifying the amount of data by linear transformation. PCA enables us to visualize experimental groups on a two-dimensional plane on the basis of the variable spot patterns. Spots of interest were identified by peptide mass fingerprinting (PMF) on an ultrafleXtreme™ MALDI-ToF/ToF instrument (Bruker Corporation, Billerica, MA, USA). Identified protein species were used to perform functional and pathways analysis by STRING software.
Statistical analysis
Data are expressed as median/IQR unless otherwise indicated. The demographic and clinical characteristics between PLHIV and PHAIDS were compared using Student's t and chisquared tests. Differences in the neurological test scores between T0 and T6 were evaluated using Student's t test. Differences in the levels of CD4 T cells expressing CD38 and HLA-DR markers in HIV-1-infected patients at T0 and T6 were evaluated using the Wilcoxon test for paired samples. The same test was used to compare the levels of protein species identified by mass spectrometry between T0 and T6. Differences were considered statistically significant when p value were less of 0.05. All analyses were performed with the SPSS v.20.0 for Windows (IBM, New York, NY, USA).
Results
Demographic and clinical characteristics of HIV-1-infected participants
In the present study, 13 HIV-1-infected subjects were enrolled: six were patients living with HIV (PLHIV) and seven patients with a condition of AIDS (PHAIDS). All patients had a mean age of 45.5 years and were virologically suppressed (HIV-RNA < 37 copies/mL). The mean CD4+ T cell count was 669.25 (IQR 493-1080) and the median duration of treatment was 10.75 years . At enrolment, median Neopterin levels were 41.36 nmol/L (IQR 31.39-70.43) for PLHIV group and 43.82 nmol/L (IQR 21.5-56). No statistically significant differences were recorded between the two groups at enrolment.
Neurocognitive evaluation
Participants were evaluated by a neuropsychologist before and after supplementation with oral probiotics. At T0, all subjects showed abnormal results in at least one test evaluating executive function and most presented a pathological impairment in two different domains. No significant differences were observed between PLHIV and PLAIDS. As shown in Table 1 , after oral bacteriotherapy supplementation, all participants showed improvement in several neurocognitive tests and at T6, all investigated subjects showed normal neurocognitive performance.
Peripheral immune activation
We compared the immune activation of PBMCs measuring the levels of CD4 T cells expressing CD38 and HLA-DR markers at T0 and after bacteriotherapy supplementation (T6). Results showed a statistically significant reduction in the percentage of CD4 + CD38 + HLA − DR + T cells at T6 (median 0.18 [IQR 0.04-0.32]) compared with T0 (median 0.80 [IQR 0.37-2.16]); p = 0.008 in both groups of patients. Aachener Aphasia Test (AAT) 9 ± 0 vs 9 ± 0 (p = 1.00)
N.A.
Trail making test A (TMT A) 52.1 ± 11.7 vs 45.5 ± 7 (p = 0.10) 
Enzyme-linked immunosorbent assay
In order to evaluate the status of inflammation before and after oral bacteriotherapy supplementation, we analyzed plasma levels of IL-6, sCD14, and MIP-1β at T0 and T6. Our results showed no significant differences in cytokine levels before [IL-6 (median 
Differential proteomic analysis
Image analysis highlighted 30 differentially abundant spots between T0 and T6 (Fig. 1 ). In addition, mass spectrometry analysis unambiguously identified 23 protein species (Table 2) . Interestingly, most of the protein species showed a decreased amount in T6 samples, including spots 14, 22, 24, 26, 27, 29, 30 (Fig. 2) , identified as hemoglobin α and β. Many of the remaining proteins could be directly related to inflammation as positive or negative reactants (β2-microglobulin p = 0.03; haptoglobin p = 0.06; albumin p = 0.003; hemoglobin p = 0.003; immunoglobulin heavy chains constant region p = 0.02, transthyretin p = 0.02) (Bini et al. 1992 (Bini et al. , 1996 .
Principal component analysis
Principal component analysis (PCA) is a multivariate analysis that correlates a high number of variables (%V) in order to evaluate whether the differential protein spots found were related to the analyzed conditions. Two Cartesian systems are reported in Fig. 3 . The graph in Fig. 3a reports the 2D space where variables with the highest variance were projected on the first axis (PC1) with a variance of 36.2%, while variables with the second highest variance (20.4%) were reported on the second axis (PC2). This is easy to observe since the distribution of each sample relies on the differential abundance of spots in CSF (spot maps). Interestingly, six out of ten T0 samples were well distinguished from T6 samples on both the PC1 and PC2 axis. Conversely, the four T0 samples that were grouped together with T6 were well separated in a second PC analysis visualizing the PC1 (36.2%) vs the PC3 (16.9%) axis (Fig. 3b ). This suggests an independent distribution of those four T0 samples (circled in green) against the T6 ones. The particular distribution of the spot maps inside the two groups is noteworthy: at T0, the distance correlation is high, and the spot maps are mainly grouped in two areas while T6 samples showed a lower distance correlation and were distributed in a well-defined area.
Cluster analysis
After protein identification, a cluster analysis was performed as shown in Fig. 4 in order to visualize how the differential protein species pattern in CSF behaved between T0 and T6. The %V mean normalized values of the 30 differentially abundant spots in T0 and T6 were organized in a hierarchical cluster. The Euclidean distance used gave us a hierarchical tree subdividing the protein spots in two major clusters on the basis of their different abundances. The first cluster holds two spots (8, 11) with an increased abundance in T6 and corresponding to transthyretin. The second cluster could be subdivided in two sub-clusters: the first one (spots 2, 1, 21, 13, 6, 19, 3, 5, 7, 12, 16, 4, 15, 18, 17, 10, 9, 20) showed a moderate decrease of protein abundance from T0 to T6 and the second represents all the protein species (spots 14, 22, 23, 24, 25, 26, 27, 28, 29, 30) showing a strong decease at T6. Fig. 1 Gel masters from T0 and T6 conditions. Differentially abundant spots are reported by red circles and numbers referred to those reported in Table 2 Table 2 Table reporting the identified proteins with the relative spot number, corresponding to that in Fig. 1, protein Enrichment analysis by STRING software STRING analysis was performed in order to elaborate an enrichment analysis, summarizing functional information about the identified proteins with respect to the three Gene Ontology categories of biological process, molecular function, and cellular component and to predict possible associations among them. STRING networks consist of nodes (spheres) representing proteins, while edges represent the predicted mode of action among proteins (Fig. 5) . The analysis was elaborated in order to connect our protein species with a maximum of five more interactors. In both networks obtained and shown in Fig. 5 , it is possible to observe the identified proteins connected with the predicted functional partners such as for coagulator factor II (thrombin, F2), transferrin receptor (TFRC), HLA-A, and HLA-B. The three colors of the spheres in Fig. 5a (green, red, and blue) identify the three clusters of functionally correlated proteins. In Fig. 5b , the different colored spheres are correlated with their respective biological processes. HBA1, HBA2, HBB, HP, ALB, and transferrin receptor (red wedge) correlate with the Breceptor-mediated endocytosis^Gene Ontology term; B2M, HLA-A, and HLA-B (blue wedge) correlate with Bantigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent^; HBA1, HBA2, HBB, HP, TFRC, and B2M (green wedge) are related to Bresponse to inorganic substance^; HBA1, HBA2, HBB (pink wedge) to Boxygen transport^and almost all of them (HBA1, HBA2, HBB, HP, TFRC, B2M, ALB, HLA-A, HLA-B, F2, and SERPINC1) (yellow wedge) to Bresponse to stress.^About molecular functions and cellular components enriched terms, interestingly, among the KEGG pathways (Kyoto Encyclopedia of Genes and Genomes), we found Bantigen processing and presentation^(HLA-A, HLA-B and B2M), Bendocytosis( HLA-A, HLA-B, and TFRC), and Bphagosome^(HLA-A, HLA-B, and TFRC) pathways, which were strongly suggested by the proteins identified in this study.
Discussion
In this study, we explored four different parameters, namely neurological condition, CSF differential proteome, inflammatory cytokines, and activated T cells before and after a specific multistrain probiotic supplementation. From a clinical point of view, we confirmed the improvement of neurological impairment observed in a group of HIV patients during cART and with undetectable levels of HIV viremia after probiotic supplementation with Vivomixx® (Ceccarelli et al. 2017a ). Our results confirmed that supplementing cART with a multistrain probiotic might favor the composition of commensal gut microbiota with immune restorative process and a return to physiological status as demonstrated in previous studies (d 'Ettorre et al. 2017) .
The supplementation of cART with oral bacteriotherapy was also reflected in the CSF proteome of these patients. In particular, our results suggest that probiotic treatment modifies protein species composition and abundance at the CSF level. Interestingly, T6 samples evidenced in PCA a lower distance correlation in a well-defined area with respect to T0 samples, indicating a differential protein pattern profile with more homogeneous behavior and suggesting a re-establishment of the protein composition and abundance in the CSF after 6 months of treatment. The prevailing reduction of several inflammatory proteins after 6 months of probiotic supplementation suggests an amelioration of the CNS inflammatory state.
Interestingly, only two spots which corresponded to transthyretin (TTR) increased at T6, in agreement with previous data showing an inverse relationship between TTR levels in the CSF and neurological inflammation (Ambalavanan et al. 2005) . Moreover, TTR is important for thyroxine (T4) transfer from blood to CSF through the blood-brain barrier (BBB) and protects the brain from β-amyloid neurotoxic accumulations into amyloid plaques, commonly observed in the early stages of Alzheimer's disease and other disorders such as schizophrenia (Chen et al. 2016; Richardson et al. 2015) . Among the abundant proteins at T0, we observed different protein species of albumin, consistent with Rahimy et al. (2017) and also spots of hemoglobin α and β, which is physiologically absent, or present at very low levels, in healthy CSF. These results strongly suggest the presence of a BBB impairment, characterized by the loss of its selective competence to regulate molecule exchange between blood vessels and the CSF, independently of disease stadiation. After 6 months of probiotic administration, the homogeneous decrease in abundance of the differential proteins suggests a possible recovery of the protective action mechanism of the BBB. Furthermore, since our CSF samples were not contaminated by blood cells during the spinal tap procedure, the marked decrease or disappearance of hemoglobin spots at T6 confirms that probiotic treatment was followed by an improvement in BBB permeability. This modification has a functional impact since products derived from hemoglobin metabolism greatly contribute to brain injury. For instance, iron promotes redox imbalance by mediating free radical generation, amplifies inflammatory response, and prevents DNA repair (Righy et al. 2018 ). Our results are also supported by the decreased-abundance of haptoglobin and N-terminal and C-terminal fragments of transferrin in 8 CSF samples at T6 as compared to T0. Haptoglobin is a plasma protein synthesized by the liver that functions by binding free hemoglobin and heme released during intravascular hemolysis, thereby removing them from circulation (Righy et al. 2018) . Its decrease at T6 therefore suggests a decreased level of inflammation. The high abundance of N-terminal and C-terminal fragments of transferrin in the CSF at T0, which tend to be reduced after 6 months of treatment, suggests that fragmentation of transferrin in cART patients plays a role in the dysfunction of the iron transport system and in its cerebral homeostasis. Mehta et al. observed an abnormal iron homeostasis in HIV neurocognitive impairment patients due to a dysregulation of iron transport in the brain (Mehta et al. 2017) . The use of probiotics seems to restore the physiological condition wherein transferrin is not degraded, therefore maintaining its protective function. Fig. 5 Protein net by STRING analysis (a). Number of nodes are 9, number of edges are 24, average node degree is 5.33, avg. local clustering coefficient is 0.731, expected number of edges are 2, and PPI enrichment p value is < 1.0e−16. The colors (light blue, red, and green) represent the three different clusters of the proteins in the net. b Colors on the sphere represent proteins correlated to a specific biological process as reported According to the KEGG pathway, the differentially abundant proteins are mainly involved in pathways corresponding to antigen processing and presentation, endocytosis, and phagosome. Of note, our study indicates that beta-2microglobulin (B2M) is particularly involved in these processes, considering that its CSF levels are directly related to the presence of inflammatory, autoimmune, or neoplastic diseases in the CNS and to disease progression in HIV patients (Svatoňová et al. 2014) . Indeed, B2M constitutes the light chain of the main proteins of the MHC I complex and increased values of B2M in CSF are found to be a sign of immune activation, abnormal turnover of lymphoid cells, and tissue damage in the CNS. A decreased amount of B2M following probiotic administration indicates an improvement in the immune status of the patient and a reduction in their inflammatory condition.
The novelty of this study is that it was able to evidence an amelioration of the CNS inflammatory state due to improved BBB permeability in the CSF of patients who experienced an improvement of their neuropsychiatric function. Surprisingly, based on prior literature suggesting potential alterations of blood-CSF permeability in HIV subjects, we were expecting that clinical and CSF improvement would be accompanied by a reduction in the abnormally high pro-inflammatory plasma cytokine levels. However, this was not observed in our patients, regardless of disease stage. The neurological condition improvement at T6 was not accompanied by any improvement in the pro-inflammatory cytokines that we measured, including IL-6, sCD14, and MIP-1β. Nevertheless, we cannot rule out that the power of statistical results has been reduced by the small sample size studied.
Indeed, a significant limitation of our study was the small sample size which consisted of only 13 patients. However, it was necessary to limit the sample size due to the invasive nature of performing a lumbar puncture, which has inherent risks. Additionally, the cost per patient of conducting this study was $10,000, which further impacted the sample size. Another limitation is that the interpretation of scores on batteries of neurocognitive tests repeated over several administrations can be complicated by the so-called practice effect: in fact, this improvement can result from patient's learning across multiple test administrations. To limit this potential risk, we chose to use alternate and parallel forms designed to avoid or reduce content-or item-specific practice effects that can be associated with repeated administrations of the same neuropsychological tests, on the basis of previous published evidences (Ceccarelli et al. 2017a, b; Getz 2011; Ferguson and Iverson 2011; Benedict and Zgaljardic 1998; Benedict 2005; Pereira et al. 2015) .
Due to the limited number of patients enrolled, we were not able to offer any correlation between the various parameters studied. However, some data are so homogeneous that some conclusions can be drawn and form the basis for larger studies in the future. For example, while the improvement of neuropsychiatric conditions in cART patients has been confirmed in this study as well as in previous studies, the mechanism by which probiotic supplementation leads to changes in brain function is not elucidated. Among the multiple hypotheses advanced, the most accepted ones involve a probioticinduced change of the gut flora metabolites or of gut permeability, and decreased systemic production of proinflammatory cytokines, with a special emphasis on TNF-α.
Additionally, the clinical improvement, amelioration of the CSF proteomic profile, and reduction in the circulating activated mononuclear cells without any modification of proinflammatory cytokines leads us to hypothesize that the use of specific multistrain probiotic may also exert a local protective mechanism at the level of the choroid plexus. In nonpathological conditions, the choroid plexus is involved in immunosurveillance and interfaces between the CNS and peripheral circulation, in addition to its role in CSF production. In a similar way, it has been demonstrated that probiotics act at the level of the tight junctions in the gut (d' Ettorre et al. 2017) . Further studies should now investigate if the tight junctions of the choroid plexus can also be protected.
